Orbuculum

Graz, Austria Founded: 2017 • Age: 9 yrs
Solutions for disease prediction via genomic data are developed.

About Orbuculum

Orbuculum is a Healthcare company based in Graz (Austria) founded in 2017 by Faiz Ahmad and Pranav Gangwal. Solutions for disease prediction via genomic data are developed. Orbuculum has raised $34.74 thousand across 2 funding rounds from investors including Axilor Ventures, Pratithi Investments and Srinath Batni. Orbuculum was last valued at $532.29 thousand in March 2020. Its Indian entity Orbuculum Genolytics Private Limited reported revenue of β‚Ή1.3 Lakh. Its focus areas include Life Sciences, Genomics, Genomics Research and Research Models.

Company details

Orbuculum was founded in 2017 and is based in Graz, Austria. Operations focus on the health technology sector, where genomic data is utilized to develop predictive solutions for diseases including cancer, cardiac conditions, neurological disorders, cardiovascular issues, and Mendelian diseases. These tools are employed by medical professionals for disease screening and prediction purposes.

Key Metrics
  • Indian entity revenue
    ₹1.3 Lakh

    FY 2024 · -82% YoY

  • Indian entity net loss
    -₹5.5 Lakh

    FY 2024 · -437% margin

  • Indian entity EBITDA
    -₹5.5 Lakh

    FY 2024 · -437% margin

  • Total Equity Funding
    $34.74K (USD)

    in 2 rounds

  • Latest Funding Round
    $19.87K (USD), Seed

    Mar 2020

  • Investors

Funding Insights of Orbuculum

Orbuculum has successfully raised a total of $34.74K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $19.87 thousand completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $34,741
  • Total Rounds 2
  • Last Round Seed β€” $19,873
  • First Round $14,868

    (May 2018)

  • Investors Count 4

All 2 funding rounds of Orbuculum with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2020$19,873Seed$532,287Axilor Ventures, Pratithi Investments
May 2018$14,868Seed$571,320Axilor Ventures, Prathithi Investment
Valuation history

Last known valuation $532,287 (Mar 2020). 4 investors in total: 3 institutional and 1 angel.

Investors in Orbuculum

Orbuculum has secured backing from 4 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Axilor Ventures, Pratithi Investments and Srinath Batni.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital firm investing in early-stage startups in technology sectors.
2014axilor.comBengaluru, India
Private investment arm of Kris Gopalakrishnan Family Office.
2014pratithi.comBengaluru, India
Healthcare and multiple sectors are targeted by the single-family office.
Bengaluru, India

Srinath Batni

Co-founder of Axilor Ventures, ex-Infosys Board Member, active angel investor
unknown_8549c1ddd5b64f4ab
Premium access

Investor details for Orbuculum

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Orbuculum Genolytics Private Limited (Orbuculum)

Orbuculum Genolytics Private Limited is the primary company behind Orbuculum. The board of Orbuculum Genolytics Private Limited currently have 2 directors; the longest-serving is Pranav Gangwal, appointed in 2017. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pranav Gangwal
DIN 07902045
Director25 Aug 20179 yrs 2 moOrbuculum Genolytics Private Limited
Prafull Kumar Gangwal
DIN 02119335
Director25 Mar 20233 yrs 7 moOrbuculum Genolytics Private Limited

People of Orbuculum

2 people are tracked at Orbuculum (2 in leadership).

NameRoleGroup
Co-FounderLeadership
Co-FounderLeadership
Premium access

Complete people profiles for Orbuculum

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Orbuculum

Figures of Orbuculum Genolytics Private Limited, the primary company behind Orbuculum, for FY 2024. Revenue was ₹1.3 Lakh (-82% year on year). Net loss was -₹5.5 Lakh (-437% margin). EBITDA was -₹5.5 Lakh (-437% margin). Revenue has grown at a compounded annual rate of +6% over three years.

  • ₹1.3 LakhRevenue · FY 2024 · -82% YoY
  • -₹5.5 LakhNet loss · -437% margin
  • -₹5.5 LakhEBITDA · -437% margin
  • ₹1.7 LakhPaid-up capital
  • 34Employees (provident fund records)
  • +6%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Orbuculum Genolytics Private Limited are on its company page.

Premium access

Detailed financial statements for Orbuculum

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Orbuculum

3 dated milestones of Orbuculum across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Orbuculum is founded.
  2. Funding First funding round of $15K.
  3. Funding Latest funding round, Seed, of $20K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Orbuculum

Orbuculum was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Orbuculum is headquartered in Graz, Austria. It is registered at Graz, Styria, Austria.

Orbuculum is a funded company, having raised a total of $34.74K across 2 funding rounds to date. The company's 1st funding round was a Seed of $14.87K, raised on May 2018.

The primary company behind Orbuculum, Orbuculum Genolytics Private Limited, reported revenue of β‚Ή1.3 Lakh for FY 2024, down 82% year on year.

Orbuculum was founded in 2017 and is based in Graz, Austria. Operations focus on the health technology sector, where genomic data is utilized to develop predictive solutions for diseases including cancer, cardiac conditions, neurological disorders, cardiovascular issues, and Mendelian diseases. These tools are employed by medical professionals for disease screening and prediction purposes.

Orbuculum has 4 investors. Key investors include Axilor Ventures, Pratithi Investments, Srinath Batni, and Prathithi Investment.

The valuation of Orbuculum is $532.29K as of Mar 2020.

Orbuculum operates through Orbuculum Genolytics Private Limited.

The legal entities of Orbuculum currently have 2 directors, including Pranav Gangwal, Prafull Kumar Gangwal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available